The Moores Cancer Center at UC San Diego Health is in imminent danger of losing its Comprehensive designation, and members of the center’s External Advisory Board are urging the leadership of the parent institution to act fast.
GP Amendment To Waxman Bill Would Leave Dollar Levels The Same But would Drop Centers Line Item
Table of Contents
YOU MAY BE INTERESTED IN
The shortage of certain cancer drugs is a serious and life-threatening issue for cancer patients across the United States. This, however, is not a new issue. Drug shortages are a cyclical event, and we need a durable solution to ensure that cancer patients have access to the drugs and the treatment they need to survive.
Last year, the NIH announced that at the direction of Congress, the organization would tighten rules for reporting sexual and workplace harassment by investigators funded by the NIH.
NCI and all five cooperative groups that make up the National Clinical Trials Network have launched a large-scale precision medicine initiative that will match cancer patients with early-phase clinical trials testing novel drug combinations that target specific tumor alterations.
In January 2021 Mary Humphrey made several phone calls to find an oncologist who would treat her husband, Marcus Humphrey, for a lump that had grown rapidly and exponentially on the right side of his neck.
Ezra Cohen was named chief medical officer of oncology at Tempus, an artificial intelligence and precision medicine company.